STOCK TITAN

STAAR Surgical (STAA) interim Co-CEO receives PSUs and share tax withholding

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

STAAR Surgical interim Co-CEO and CFO Deborah J. Andrews reported equity compensation activity tied to performance stock units that vested on May 15, 2026. Two tranches of performance stock units under the 2025 PSU Program settled into 10,466 and 5,233 shares of common stock after the Compensation Committee certified performance results.

To cover tax obligations on these vestings, the company withheld 3,755 and 1,877 shares, reported as tax-withholding dispositions at about $32.07 per share. After these non‑market transactions, Andrews directly held 15,297 shares of STAAR Surgical common stock. The filing reflects routine compensation and tax withholding, not open‑market buying or selling.

Positive

  • None.

Negative

  • None.
Insider ANDREWS DEBORAH J
Role Interim Co-CEO and CFO
Type Security Shares Price Value
Exercise Performance Stock Units 10,466 $0.00 --
Exercise Performance Stock Units 5,233 $0.00 --
Grant/Award Common Stock 10,466 $0.00 --
Tax Withholding Common Stock 3,755 $32.07 $120K
Grant/Award Common Stock 5,233 $0.00 --
Tax Withholding Common Stock 1,877 $32.07 $60K
Holdings After Transaction: Performance Stock Units — 10,466 shares (Direct, null); Common Stock — 10,466 shares (Direct, null)
Footnotes (1)
  1. On May 15, 2026, the first tranche of 10,466 performance stock units ("PSUs") awarded to the Reporting Person under the Issuer's 2025 Performance Stock Unit Award Program ("2025 PSU Program") in connection with her new hire grant vested, of which 3,755 shares were withheld to satisfy taxes . On May 15, 2026, the second tranche of 5,233 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with her new hire grant vested, of which 1,877 shares were withheld to satisfy taxes. Represents the settlement of the first tranche of performance stock units awarded to the Reporting Person in connection with her new hire grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. Represents the settlement of the second tranche of performance stock units awarded to the Reporting Person in connection with her new hire grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
First PSU tranche vested 10,466 shares Common stock from first performance stock unit tranche on May 15, 2026
Second PSU tranche vested 5,233 shares Common stock from second performance stock unit tranche on May 15, 2026
Tax withholding (first tranche) 3,755 shares Shares withheld to satisfy taxes, F-code transaction at ~$32.07
Tax withholding (second tranche) 1,877 shares Shares withheld to satisfy taxes, F-code transaction at ~$32.07
Effective price for withholding $32.07 per share Price used for tax-withholding dispositions of common stock
Post-transaction holdings 15,297 shares Deborah Andrews’ direct common stock holdings after transactions
Derivative PSUs exercised 15,699 units Performance stock units converted into common stock (M-code transactions)
Performance Stock Units financial
"On May 15, 2026, the first tranche of 10,466 performance stock units ("PSUs") awarded to the Reporting Person..."
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
2025 Performance Stock Unit Award Program financial
"PSUs awarded to the Reporting Person under the Issuer's 2025 Performance Stock Unit Award Program ("2025 PSU Program")..."
tax-withholding disposition financial
"of which 3,755 shares were withheld to satisfy taxes ."
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
Compensation Committee financial
"The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals."
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
Rule 16b-3(d) regulatory
"The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported."
Rule 16b-3(d) is a narrow SEC safe-harbor that shields company insiders (officers, directors and large shareholders) from liability for short‑swing profits when their buys or sells of company stock are made under a pre-established, written plan or contract that removes the insider’s ability to time trades. For investors, this matters because it permits predictable, automated insider transactions — like scheduled sales for diversification or payroll withholding — without triggering forced disgorgement, so such planned trades are treated differently from opportunistic insider trading.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ANDREWS DEBORAH J

(Last)(First)(Middle)
25510 COMMERCENTRE DRIVE

(Street)
LAKE FOREST CALIFORNIA 92630

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
STAAR SURGICAL CO [ STAA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Interim Co-CEO and CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/15/2026A10,466A$010,466D
Common Stock05/15/2026F3,755(1)D$32.0715,297D
Common Stock05/15/2026A5,233A$020,530D
Common Stock05/15/2026F1,877(2)D$32.0718,653D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Performance Stock Units$005/15/2026M10,466 (3)12/31/2027Common Stock10,466$010,466D
Performance Stock Units$005/15/2026M5,233 (4)12/31/2027Common Stock5,233$015,699D
Explanation of Responses:
1. On May 15, 2026, the first tranche of 10,466 performance stock units ("PSUs") awarded to the Reporting Person under the Issuer's 2025 Performance Stock Unit Award Program ("2025 PSU Program") in connection with her new hire grant vested, of which 3,755 shares were withheld to satisfy taxes .
2. On May 15, 2026, the second tranche of 5,233 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with her new hire grant vested, of which 1,877 shares were withheld to satisfy taxes.
3. Represents the settlement of the first tranche of performance stock units awarded to the Reporting Person in connection with her new hire grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
4. Represents the settlement of the second tranche of performance stock units awarded to the Reporting Person in connection with her new hire grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
Remarks:
The Issuer's 2025 Performance Stock Unit Award Program ("2025 PSU Program") was designed to incentivize growth over a multi-year period. Under the 2025 PSU Program, performance is measured based on the Company's trailing four-quarter revenue through the end of fiscal 2027. The performance stock units ("PSUs") were granted based on a target number of shares and can be earned between 0-200 percent of target based on Company performance. The PSUs were structured into five tranches, each with different targets for trailing four-quarter U.S. GAAP revenue. Trailing four quarter U.S. GAAP revenue is measured as of the end of each financial quarter, commencing with the fourth quarter of fiscal 2025 and continuing through the fourth quarter of fiscal 2027. If none of the targets are achieved as of the end of fiscal 2027, the PSUs will not be earned and be forfeited. If the first three targets are achieved as of the end of fiscal 2027, the PSUs will be earned at 100 percent of target. If all five targets are achieved as of the end of fiscal 2027, the PSUs will be earned at 200 percent of target. Each PSU represents the right to receive one share of the Issuer's common stock.
/s/ Deborah J. Andrews05/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did STAAR Surgical (STAA) report for Deborah Andrews?

Deborah J. Andrews reported vesting and settlement of performance stock units into common stock and related tax-withholding share dispositions. These transactions reflect equity compensation under the 2025 PSU Program rather than open‑market purchases or sales, and adjust her direct ownership in STAAR Surgical shares.

How many STAAR Surgical shares did Deborah Andrews receive from PSU vesting?

Two PSU tranches vested into 10,466 and 5,233 common shares for Deborah Andrews on May 15, 2026. These shares were earned under the 2025 Performance Stock Unit Award Program after the Compensation Committee certified achievement of the applicable performance goals for her new hire grant.

How many STAAR Surgical shares were withheld for Deborah Andrews’ taxes?

STAAR Surgical withheld 3,755 and 1,877 shares of common stock from Deborah Andrews’ PSU settlements to satisfy tax liabilities. These F‑code transactions are tax-withholding dispositions at about $32.07 per share, not discretionary open‑market sales by the executive.

What is Deborah Andrews’ STAAR Surgical share ownership after these Form 4 transactions?

Following the reported transactions, Deborah Andrews directly held 15,297 shares of STAAR Surgical common stock. This figure reflects her position after PSU settlements converted into shares and a portion of those shares was withheld to cover taxes on May 15, 2026.

What is the 2025 PSU Program mentioned in STAAR Surgical’s Form 4?

The 2025 Performance Stock Unit Award Program grants performance-based stock units that can settle into common shares if defined goals are achieved. For Deborah Andrews, the number of shares earned was determined after the Compensation Committee certified performance against those program goals.

Were Deborah Andrews’ original PSU grants previously reported by STAAR Surgical?

The filing states the original PSU grants were exempt and not previously reported under Rule 16b-3(d). The current Form 4 instead reports the settlement of those performance stock units into common shares once performance goals were certified and the awards vested.